These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 489070)

  • 1. Pharmacology of 4'fluoro-3-(1-piperidyl) propiophenone (compound CN), a new centrally acting skeletal muscle relaxant.
    Patnaik GK; Sabir M; Dhawan BN
    Indian J Exp Biol; 1979 Apr; 17(4):397-400. PubMed ID: 489070
    [No Abstract]   [Full Text] [Related]  

  • 2. Central muscle relaxant activity of 4'-fluoro-3-(1-piperidyl) propiophenone (compound CN).
    Patnaik GK; Sabir M; Dhawan BN
    Indian J Exp Biol; 1979 Apr; 17(4):391-6. PubMed ID: 489069
    [No Abstract]   [Full Text] [Related]  

  • 3. [General pharmacology of 6-amino-2-fluoromethyl-3-(o-tolyl)-4(3H)-quinazolinone (afloqualone), a new centrally acting muscle relaxant. II. Effects on the peripheral system (author's transl)].
    Ochiai T; Fukuchi I; Ego H; Yamamura M; Kudo Y; Ishida R
    Nihon Yakurigaku Zasshi; 1981 Oct; 78(4):359-80. PubMed ID: 7327456
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacology of a new centrally acting muscle relaxant (RJ-64).
    Leszkovszky GP; Tardos L
    Arzneimittelforschung; 1970 Nov; 20(11):1778-83. PubMed ID: 4321623
    [No Abstract]   [Full Text] [Related]  

  • 5. [Pharmacological and toxicological studies on the effect characterization of etafenone].
    Hapke HJ; Sterner W
    Arzneimittelforschung; 1969 Oct; 19(10):1664-72. PubMed ID: 5395365
    [No Abstract]   [Full Text] [Related]  

  • 6. Pharmacological studies of the new centrally acting muscle relaxant 4'-ethyl-2-methyl-3-pyrrolidinopropiophenone hydrochloride.
    Morikawa K; Oshita M; Yamazaki M; Ohara N; Mizutani F; Kato H; Ito Y; Kontani H; Koshiura R
    Arzneimittelforschung; 1987 Mar; 37(3):331-6. PubMed ID: 3593447
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacological properties of the new centrally acting muscle relaxant (R)-(+)-3-phenyl-5-[2-(1-pyrrolidinylmethyl)butyryl]isoxazole hydrochloride.
    Otsu T; Kawabata H; Horikomi K; Tanada H; Sakai K; Matsubara A; Mizuchi A
    Arzneimittelforschung; 1997 Jun; 47(6):706-9. PubMed ID: 9239447
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Pharmacological studies on bisatropinium bromide, a new muscle relaxant].
    Chen GK; Fang RY; Zhang YP
    Yao Xue Xue Bao; 1984 Jan; 19(1):21-7. PubMed ID: 6477678
    [No Abstract]   [Full Text] [Related]  

  • 9. [Experimental comparative study of the secondary effects of dextromoramide, of fentanyl and of phenoperidine].
    Roquebert J; Canellas J; Dumartin A; Sabathié M
    Arch Int Pharmacodyn Ther; 1967 Jun; 167(2):297-307. PubMed ID: 6069939
    [No Abstract]   [Full Text] [Related]  

  • 10. [General pharmacological effects of flupentixol].
    Ueki S; Watanabe S; Morimot Y; Masuda M
    Igaku Kenkyu; 1971 Jul; 41(5):441-51. PubMed ID: 5165981
    [No Abstract]   [Full Text] [Related]  

  • 11. Effect of a centrally-acting muscle relaxant, eperisone hydrochloride, on muscle sympathetic nerve activity in humans.
    Iwase S; Mano T; Saito M; Ishida G
    Funct Neurol; 1992; 7(6):459-70. PubMed ID: 1338431
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Pharmacologial studies on a centrally acting muscle relaxant, chlorphenesin carbamate, with special reference to the effect on the motor system].
    Fukuda H; Kudo Y; Ono H; Kokubo M
    Nihon Yakurigaku Zasshi; 1974 May; 70(3):341-58. PubMed ID: 4280376
    [No Abstract]   [Full Text] [Related]  

  • 13. Physiological pharmacokinetics of a new muscle-relaxant, inaperisone, combined with its pharmacological effect on blood flow rate.
    Nagata O; Murata M; Kato H; Terasaki T; Sato H; Tsuji A
    Drug Metab Dispos; 1990; 18(6):902-10. PubMed ID: 1981535
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Pharmacology of dimethylaminoethyl ester of diphenylethoxyacetic acid hydrochloride--estocin].
    Kingisepp GIa; Kurvits KhKh; Nurmand LB
    Farmakol Toksikol; 1969; 32(6):710-2. PubMed ID: 5381602
    [No Abstract]   [Full Text] [Related]  

  • 15. Potentiation of catecholamines by a new diphenylalkanolamine. I. Studies in vivo and general pharmacology.
    Kasuya Y; Watanabe M
    Arzneimittelforschung; 1965 Nov; 15(11):1279-84. PubMed ID: 4382189
    [No Abstract]   [Full Text] [Related]  

  • 16. Pharmacological profile of N-(2,6-DIMETHYLPHENYL)-N-(1-methyl-2pyrrolidinylidene)urea, xilobam, a new centrally acting skeletal muscle relaxant.
    Gardocki JF; Hageman WE; Pruss TP
    Arch Int Pharmacodyn Ther; 1978 Jun; 233(2):326-42. PubMed ID: 99099
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Centrally acting muscle relaxant activities of 2-methyl-3-pyrrolidinopropiophenone derivatives].
    Yamazaki M; Aoki Y; Kato H; Ito Y; Kontani H; Koshiura R
    Yakugaku Zasshi; 1987 Sep; 107(9):705-10. PubMed ID: 3437397
    [No Abstract]   [Full Text] [Related]  

  • 18. [Pharmacological studies of cefatrizine (S-640P) (author's transl)].
    Matsuzaki M; Onodera K; Okazaki I; Nakajima A; Kishimoto K
    Jpn J Antibiot; 1976 Jan; 29(1):107-21. PubMed ID: 1263334
    [No Abstract]   [Full Text] [Related]  

  • 19. Pharmacological properties of a propiophenone derivative.
    McColl JD; Lee CF
    Arch Int Pharmacodyn Ther; 1967 Aug; 168(2):392-9. PubMed ID: 6049333
    [No Abstract]   [Full Text] [Related]  

  • 20. Some observations on the pharmacology of mitragynine.
    Macko E; Weisbach JA; Douglas B
    Arch Int Pharmacodyn Ther; 1972; 198(1):145-61. PubMed ID: 4626477
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.